Cyclohexane, 1-ethoxy-2-(1-methylethyl)-

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Cyclohexane, 1-ethoxy-2-(1-methylethyl)-
• 英文别名: 1-ethoxy-2-propan-2-ylcyclohexane
• 化学式: C₁₁H₂₂O
• 分子量: 170.29
• InChiKey: XGVWNKVLHIGQSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• RHINOLOGICA
  申请人：Symrise GmbH & Co. KG

  公开号：EP1341512B1

  公开（公告）日：2008-12-31
• Rhinologically active substances
  申请人：——

  公开号：US20020120014A1

  公开（公告）日：2002-08-29

  Acyclic ethers can be used as rhinologically active substances. In the regions of the mouth, the throat and the airways they produce a refreshing and clearing feeling.
• UTILIZATION OF RHINOLOGICALLY ACTIVE SUBSTANCES
  申请人：Surburg Horst

  公开号：US20080274064A1

  公开（公告）日：2008-11-06

  Acyclic compounds containing an ethers functionality external to the ring can be used as rhinologically active substances. In the regions of the mouth, the throat and the airways they produce a refreshing and clearing feeling.
• ERK INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20170266167A1

  公开（公告）日：2017-09-21

  The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and a pharmaceutically acceptable carrier. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and an effective amount of at least one other pharmaceutically active ingredient (such as, for example, a chemotherapeutic agent), and a pharmaceutically acceptable carrier.
• US7414079B2
  申请人：——

  公开号：US7414079B2

  公开（公告）日：2008-08-19